The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Understanding the current state of clinical trials, this discussion will highlight the integral role of the navigator in providing assessment, education, and support for patients with cancer considering clinical trial options.
Learning Objectives:
Provide a general overview of the clinical trial process
Explore how the pandemic has impacted the conduct of clinical trials
Educate navigators regarding questions to assess patients support for clinical trial enrollment
Identify barriers to enrollment
Discuss current sources of support for patients with cancer considering clinical trial enrollment
Summarize strategies navigators can utilize to support patients participating in clinical trials
Speaker(s):
Linda
Burhansstipanov,
MSPH, DrPH,
President,
Native American Cancer Initiatives, Incorporation (NACI)
Linda
U. Krebs,
PhD, RN, AOCN, FAAN,
Associate Professor Emerita,
University of Colorado College of Nursing
Daniel
G. Petereit,
MD, FASTRO,
Radiation Oncologist Principal Investigator, Walking Forward,
"Cancer Care Institute at Monument Health Avera Health"
You must be logged in and own this session in order to
post comments.
